HEADER TRANSCRIPTION 09-MAR-01 1I7I TITLE CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMAN TITLE 2 PPAR-GAMMA IN COMPLEX WITH THE AGONIST AZ 242 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: PPAR-GAMMA; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ANTI PARALLEL HELIX SANDWICH, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR J.F.W.PETERSEN,P.CRONET,R.FOLMER,N.BLOMBERG,K.SJOBLOM, AUTHOR 2 U.KARLSSON,E.-L.LINDSTEDT,K.BAMBERG REVDAT 3 24-FEB-09 1I7I 1 VERSN REVDAT 2 01-APR-03 1I7I 1 JRNL REVDAT 1 09-MAR-02 1I7I 0 JRNL AUTH P.CRONET,J.F.PETERSEN,R.FOLMER,N.BLOMBERG, JRNL AUTH 2 K.SJOBLOM,U.KARLSSON,E.L.LINDSTEDT,K.BAMBERG JRNL TITL STRUCTURE OF THE PPARALPHA AND -GAMMA LIGAND JRNL TITL 2 BINDING DOMAIN IN COMPLEX WITH AZ 242; LIGAND JRNL TITL 3 SELECTIVITY AND AGONIST ACTIVATION IN THE PPAR JRNL TITL 4 FAMILY. JRNL REF STRUCTURE V. 9 699 2001 JRNL REFN ISSN 0969-2126 JRNL PMID 11587644 JRNL DOI 10.1016/S0969-2126(01)00634-7 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 2.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2000 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.98 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1562646.620 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.3 REMARK 3 NUMBER OF REFLECTIONS : 25313 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.238 REMARK 3 FREE R VALUE : 0.284 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1224 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.35 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.50 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4076 REMARK 3 BIN R VALUE (WORKING SET) : 0.3240 REMARK 3 BIN FREE R VALUE : 0.3440 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 205 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.024 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4132 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 62 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 41.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.67000 REMARK 3 B22 (A**2) : 7.31000 REMARK 3 B33 (A**2) : -4.64000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 9.36000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM SIGMAA (A) : 0.32 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.33 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.20 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.77 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.500 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.470 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.770 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.840 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : C1.PAR REMARK 3 PARAMETER FILE 3 : WATER.PARAM REMARK 3 PARAMETER FILE 4 : CIS_PEPTIDE.PARAM REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : C1.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1I7I COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-MAR-01. REMARK 100 THE RCSB ID CODE IS RCSB013001. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25345 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.350 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.3 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.43 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.41900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY: 2PRG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM CITRATE, HEPES, PH 7.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 46.46400 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.89050 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 46.46400 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 30.89050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 186 REMARK 465 SER A 187 REMARK 465 HIS A 188 REMARK 465 MET A 189 REMARK 465 ALA A 190 REMARK 465 GLU A 191 REMARK 465 ILE A 192 REMARK 465 SER A 193 REMARK 465 SER A 194 REMARK 465 ASP A 195 REMARK 465 ILE A 196 REMARK 465 ILE A 197 REMARK 465 SER A 198 REMARK 465 SER A 199 REMARK 465 ASP A 200 REMARK 465 ILE A 201 REMARK 465 ASP A 202 REMARK 465 GLN A 203 REMARK 465 LEU A 204 REMARK 465 ASN A 205 REMARK 465 PRO A 206 REMARK 465 PHE A 264 REMARK 465 LYS A 265 REMARK 465 HIS A 266 REMARK 465 ILE A 267 REMARK 465 THR A 268 REMARK 465 PRO A 269 REMARK 465 LEU A 270 REMARK 465 GLN A 271 REMARK 465 GLU A 272 REMARK 465 GLN A 273 REMARK 465 SER A 274 REMARK 465 LYS A 275 REMARK 465 TYR A 477 REMARK 465 GLY B 186 REMARK 465 SER B 187 REMARK 465 HIS B 188 REMARK 465 MET B 189 REMARK 465 ALA B 190 REMARK 465 GLU B 191 REMARK 465 ILE B 192 REMARK 465 SER B 193 REMARK 465 SER B 194 REMARK 465 ASP B 195 REMARK 465 ILE B 196 REMARK 465 ILE B 197 REMARK 465 SER B 198 REMARK 465 SER B 199 REMARK 465 ASP B 200 REMARK 465 ILE B 201 REMARK 465 ASP B 202 REMARK 465 GLN B 203 REMARK 465 LEU B 204 REMARK 465 ASN B 205 REMARK 465 PRO B 206 REMARK 465 THR B 268 REMARK 465 PRO B 269 REMARK 465 LEU B 270 REMARK 465 GLN B 271 REMARK 465 GLU B 272 REMARK 465 GLN B 273 REMARK 465 SER B 274 REMARK 465 ASP B 462 REMARK 465 MET B 463 REMARK 465 LYS B 474 REMARK 465 ASP B 475 REMARK 465 LEU B 476 REMARK 465 TYR B 477 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 242 24.75 -71.75 REMARK 500 LYS A 244 107.08 -166.51 REMARK 500 LYS A 358 -80.35 12.99 REMARK 500 ASP A 362 5.60 -152.17 REMARK 500 LEU A 393 59.04 -93.51 REMARK 500 SER A 394 -73.18 -73.07 REMARK 500 LYS A 474 108.23 -56.49 REMARK 500 ASP A 475 112.66 61.29 REMARK 500 LEU B 237 -147.93 -62.62 REMARK 500 THR B 238 -44.96 -25.53 REMARK 500 LYS B 240 -82.87 -49.21 REMARK 500 THR B 242 64.11 -62.48 REMARK 500 LYS B 244 83.91 161.50 REMARK 500 GLU B 276 150.52 -37.62 REMARK 500 SER B 355 54.87 -109.42 REMARK 500 PRO B 359 34.78 -92.54 REMARK 500 SER B 394 -74.25 -67.88 REMARK 500 LYS B 457 38.79 -67.15 REMARK 500 LYS B 458 40.93 -148.23 REMARK 500 THR B 459 -52.49 -159.75 REMARK 500 HIS B 466 -30.04 164.77 REMARK 500 PRO B 467 -84.75 -33.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AZ2 A 101 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AZ2 B 478 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1I7G RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN FROM HUMAN REMARK 900 PPAR-ALPHA IN COMPLEX WITH THE AGONIST AZ 242 DBREF 1I7I A 197 477 UNP P37231 PPAT_HUMAN 225 505 DBREF 1I7I B 197 477 UNP P37231 PPAT_HUMAN 225 505 SEQADV 1I7I GLY A 186 UNP P37231 CLONING ARTIFACT SEQADV 1I7I SER A 187 UNP P37231 CLONING ARTIFACT SEQADV 1I7I HIS A 188 UNP P37231 CLONING ARTIFACT SEQADV 1I7I MET A 189 UNP P37231 CLONING ARTIFACT SEQADV 1I7I ALA A 190 UNP P37231 CLONING ARTIFACT SEQADV 1I7I GLU A 191 UNP P37231 CLONING ARTIFACT SEQADV 1I7I ILE A 192 UNP P37231 CLONING ARTIFACT SEQADV 1I7I SER A 193 UNP P37231 CLONING ARTIFACT SEQADV 1I7I SER A 194 UNP P37231 CLONING ARTIFACT SEQADV 1I7I ASP A 195 UNP P37231 CLONING ARTIFACT SEQADV 1I7I ILE A 196 UNP P37231 CLONING ARTIFACT SEQADV 1I7I GLY B 186 UNP P37231 CLONING ARTIFACT SEQADV 1I7I SER B 187 UNP P37231 CLONING ARTIFACT SEQADV 1I7I HIS B 188 UNP P37231 CLONING ARTIFACT SEQADV 1I7I MET B 189 UNP P37231 CLONING ARTIFACT SEQADV 1I7I ALA B 190 UNP P37231 CLONING ARTIFACT SEQADV 1I7I GLU B 191 UNP P37231 CLONING ARTIFACT SEQADV 1I7I ILE B 192 UNP P37231 CLONING ARTIFACT SEQADV 1I7I SER B 193 UNP P37231 CLONING ARTIFACT SEQADV 1I7I SER B 194 UNP P37231 CLONING ARTIFACT SEQADV 1I7I ASP B 195 UNP P37231 CLONING ARTIFACT SEQADV 1I7I ILE B 196 UNP P37231 CLONING ARTIFACT SEQRES 1 A 292 GLY SER HIS MET ALA GLU ILE SER SER ASP ILE ILE SER SEQRES 2 A 292 SER ASP ILE ASP GLN LEU ASN PRO GLU SER ALA ASP LEU SEQRES 3 A 292 ARG ALA LEU ALA LYS HIS LEU TYR ASP SER TYR ILE LYS SEQRES 4 A 292 SER PHE PRO LEU THR LYS ALA LYS ALA ARG ALA ILE LEU SEQRES 5 A 292 THR GLY LYS THR THR ASP LYS SER PRO PHE VAL ILE TYR SEQRES 6 A 292 ASP MET ASN SER LEU MET MET GLY GLU ASP LYS ILE LYS SEQRES 7 A 292 PHE LYS HIS ILE THR PRO LEU GLN GLU GLN SER LYS GLU SEQRES 8 A 292 VAL ALA ILE ARG ILE PHE GLN GLY CYS GLN PHE ARG SER SEQRES 9 A 292 VAL GLU ALA VAL GLN GLU ILE THR GLU TYR ALA LYS SER SEQRES 10 A 292 ILE PRO GLY PHE VAL ASN LEU ASP LEU ASN ASP GLN VAL SEQRES 11 A 292 THR LEU LEU LYS TYR GLY VAL HIS GLU ILE ILE TYR THR SEQRES 12 A 292 MET LEU ALA SER LEU MET ASN LYS ASP GLY VAL LEU ILE SEQRES 13 A 292 SER GLU GLY GLN GLY PHE MET THR ARG GLU PHE LEU LYS SEQRES 14 A 292 SER LEU ARG LYS PRO PHE GLY ASP PHE MET GLU PRO LYS SEQRES 15 A 292 PHE GLU PHE ALA VAL LYS PHE ASN ALA LEU GLU LEU ASP SEQRES 16 A 292 ASP SER ASP LEU ALA ILE PHE ILE ALA VAL ILE ILE LEU SEQRES 17 A 292 SER GLY ASP ARG PRO GLY LEU LEU ASN VAL LYS PRO ILE SEQRES 18 A 292 GLU ASP ILE GLN ASP ASN LEU LEU GLN ALA LEU GLU LEU SEQRES 19 A 292 GLN LEU LYS LEU ASN HIS PRO GLU SER SER GLN LEU PHE SEQRES 20 A 292 ALA LYS LEU LEU GLN LYS MET THR ASP LEU ARG GLN ILE SEQRES 21 A 292 VAL THR GLU HIS VAL GLN LEU LEU GLN VAL ILE LYS LYS SEQRES 22 A 292 THR GLU THR ASP MET SER LEU HIS PRO LEU LEU GLN GLU SEQRES 23 A 292 ILE TYR LYS ASP LEU TYR SEQRES 1 B 292 GLY SER HIS MET ALA GLU ILE SER SER ASP ILE ILE SER SEQRES 2 B 292 SER ASP ILE ASP GLN LEU ASN PRO GLU SER ALA ASP LEU SEQRES 3 B 292 ARG ALA LEU ALA LYS HIS LEU TYR ASP SER TYR ILE LYS SEQRES 4 B 292 SER PHE PRO LEU THR LYS ALA LYS ALA ARG ALA ILE LEU SEQRES 5 B 292 THR GLY LYS THR THR ASP LYS SER PRO PHE VAL ILE TYR SEQRES 6 B 292 ASP MET ASN SER LEU MET MET GLY GLU ASP LYS ILE LYS SEQRES 7 B 292 PHE LYS HIS ILE THR PRO LEU GLN GLU GLN SER LYS GLU SEQRES 8 B 292 VAL ALA ILE ARG ILE PHE GLN GLY CYS GLN PHE ARG SER SEQRES 9 B 292 VAL GLU ALA VAL GLN GLU ILE THR GLU TYR ALA LYS SER SEQRES 10 B 292 ILE PRO GLY PHE VAL ASN LEU ASP LEU ASN ASP GLN VAL SEQRES 11 B 292 THR LEU LEU LYS TYR GLY VAL HIS GLU ILE ILE TYR THR SEQRES 12 B 292 MET LEU ALA SER LEU MET ASN LYS ASP GLY VAL LEU ILE SEQRES 13 B 292 SER GLU GLY GLN GLY PHE MET THR ARG GLU PHE LEU LYS SEQRES 14 B 292 SER LEU ARG LYS PRO PHE GLY ASP PHE MET GLU PRO LYS SEQRES 15 B 292 PHE GLU PHE ALA VAL LYS PHE ASN ALA LEU GLU LEU ASP SEQRES 16 B 292 ASP SER ASP LEU ALA ILE PHE ILE ALA VAL ILE ILE LEU SEQRES 17 B 292 SER GLY ASP ARG PRO GLY LEU LEU ASN VAL LYS PRO ILE SEQRES 18 B 292 GLU ASP ILE GLN ASP ASN LEU LEU GLN ALA LEU GLU LEU SEQRES 19 B 292 GLN LEU LYS LEU ASN HIS PRO GLU SER SER GLN LEU PHE SEQRES 20 B 292 ALA LYS LEU LEU GLN LYS MET THR ASP LEU ARG GLN ILE SEQRES 21 B 292 VAL THR GLU HIS VAL GLN LEU LEU GLN VAL ILE LYS LYS SEQRES 22 B 292 THR GLU THR ASP MET SER LEU HIS PRO LEU LEU GLN GLU SEQRES 23 B 292 ILE TYR LYS ASP LEU TYR HET AZ2 A 101 28 HET AZ2 B 478 28 HETNAM AZ2 (2S)-2-ETHOXY-3-[4-(2-{4-[(METHYLSULFONYL) HETNAM 2 AZ2 OXY]PHENYL}ETHOXY)PHENYL]PROPANOIC ACID HETSYN AZ2 AZ 242 FORMUL 3 AZ2 2(C20 H24 O7 S) FORMUL 5 HOH *62(H2 O) HELIX 1 1 GLU A 207 PHE A 226 1 20 HELIX 2 2 THR A 229 THR A 238 1 10 HELIX 3 3 ASP A 251 ILE A 262 1 12 HELIX 4 4 GLU A 276 SER A 302 1 27 HELIX 5 5 GLY A 305 LEU A 309 5 5 HELIX 6 6 ASP A 310 SER A 332 1 23 HELIX 7 7 SER A 342 GLY A 344 5 3 HELIX 8 8 ARG A 350 SER A 355 1 6 HELIX 9 9 MET A 364 ALA A 376 1 13 HELIX 10 10 ASP A 380 LEU A 393 1 14 HELIX 11 11 ASN A 402 HIS A 425 1 24 HELIX 12 12 GLN A 430 GLU A 460 1 31 HELIX 13 13 HIS A 466 LYS A 474 1 9 HELIX 14 14 GLU B 207 PHE B 226 1 20 HELIX 15 15 THR B 229 LEU B 237 1 9 HELIX 16 16 ASP B 251 ILE B 262 1 12 HELIX 17 17 GLU B 276 ILE B 303 1 28 HELIX 18 18 GLY B 305 LEU B 309 5 5 HELIX 19 19 ASP B 310 ALA B 331 1 22 HELIX 20 20 ARG B 350 SER B 355 1 6 HELIX 21 21 MET B 364 ALA B 376 1 13 HELIX 22 22 ASP B 380 LEU B 393 1 14 HELIX 23 23 ASN B 402 HIS B 425 1 24 HELIX 24 24 GLN B 430 LYS B 457 1 28 HELIX 25 25 HIS B 466 GLU B 471 1 6 SHEET 1 A 4 PHE A 247 ILE A 249 0 SHEET 2 A 4 GLY A 346 THR A 349 1 O PHE A 347 N ILE A 249 SHEET 3 A 4 GLY A 338 ILE A 341 -1 N VAL A 339 O MET A 348 SHEET 4 A 4 MET A 334 ASN A 335 -1 N ASN A 335 O GLY A 338 SHEET 1 B 4 PHE B 247 ILE B 249 0 SHEET 2 B 4 GLY B 346 THR B 349 1 O PHE B 347 N ILE B 249 SHEET 3 B 4 GLY B 338 ILE B 341 -1 N VAL B 339 O MET B 348 SHEET 4 B 4 MET B 334 ASN B 335 -1 N ASN B 335 O GLY B 338 CISPEP 1 LYS B 358 PRO B 359 0 0.67 SITE 1 AC1 10 PHE A 282 GLY A 284 CYS A 285 SER A 289 SITE 2 AC1 10 HIS A 323 MET A 348 MET A 364 HIS A 449 SITE 3 AC1 10 LEU A 469 TYR A 473 SITE 1 AC2 12 PHE B 264 HIS B 266 ILE B 281 PHE B 282 SITE 2 AC2 12 GLY B 284 CYS B 285 SER B 289 HIS B 323 SITE 3 AC2 12 ILE B 341 MET B 348 MET B 364 HIS B 449 CRYST1 92.928 61.781 118.981 90.00 101.52 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010761 0.000000 0.002193 0.00000 SCALE2 0.000000 0.016186 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008577 0.00000